Pyrazolopyridine and pyrrolopyridine multikinase inhibitors
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US08299252B2
公开(公告)日:2012-10-30
It is intended to provide a compound represented by the formula (1):
[wherein Ar is an arylene group to be attached selected from the following formula (2):
(wherein * represents a binding site to a nitrogen atom and ** represents a binding site to T); T represents —(O)n—R; R represents a C1-C6 alkyl group or the like; n represents 0 or 1; X represents O or the like; R2, R3 and R4 are independently selected from a hydrogen atom or C1-C3 alkyl; or R2 and R3 may join together with an urea structure containing the nitrogen atoms to which they bind to form a 5- or 6-membered heterocycle; Y represents CH or N], or a pharmaceutically acceptable salt thereof or a prodrug thereof and a pharmaceutical composition containing the same.